Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment

The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer syndromes can lead to reductions in morbidity and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PeerJ
Autors principals: Vysotskaia, Valentina S., Hogan, Gregory J., Gould, Genevieve M., Wang, Xin, Robertson, Alex D., Haas, Kevin R., Theilmann, Mark R., Spurka, Lindsay, Grauman, Peter V., Lai, Henry H., Jeon, Diana, Haliburton, Genevieve, Leggett, Matt, Chu, Clement S., Iori, Kevin, Maguire, Jared R., Ready, Kaylene, Evans, Eric A., Kang, Hyunseok P., Haque, Imran S.
Format: Artigo
Idioma:Inglês
Publicat: PeerJ Inc. 2017
Matèries:
Genomics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5326550/
https://ncbi.nlm.nih.gov/pubmed/28243543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.3046
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars